167 related articles for article (PubMed ID: 36536977)
1. Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma.
Kang H; Tao Y
Int J Ophthalmol; 2022; 15(12):1893-1902. PubMed ID: 36536977
[TBL] [Abstract][Full Text] [Related]
2. Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Zhou X; Shi H; Li Y; Huang H; Ma Y; Chen B; Wang Q; Guan M
J Clin Lab Anal; 2022 Oct; 36(10):e24689. PubMed ID: 36098043
[TBL] [Abstract][Full Text] [Related]
3. Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
Kim RY; Park JH; Kim M; Park YG; Cho SG; Park YH
PLoS One; 2021; 16(11):e0260469. PubMed ID: 34813633
[TBL] [Abstract][Full Text] [Related]
4. APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Wang D; Zhou X; Li X; Shi H; Li Y; Cao X; Guan M; Chen B; Wang Q
Clin Chim Acta; 2022 Oct; 535():1-6. PubMed ID: 35820532
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma.
Raja H; Snyder MR; Johnston PB; O'Neill BP; Caraballo JN; Balsanek JG; Peters BE; Decker PA; Pulido JS
PLoS One; 2013; 8(6):e65627. PubMed ID: 23750271
[TBL] [Abstract][Full Text] [Related]
6. USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA.
Pochat-Cotilloux C; Bienvenu J; Nguyen AM; Ohanessian R; Ghesquières H; Sève P; Garnier L; Kodjikian L
Retina; 2018 Apr; 38(4):773-781. PubMed ID: 29135797
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
[TBL] [Abstract][Full Text] [Related]
8. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
[TBL] [Abstract][Full Text] [Related]
9. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.
Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN
Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914
[TBL] [Abstract][Full Text] [Related]
10. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.
de Hoog J; Dik WA; Lu L; Heezen KC; Ten Berge JC; Swagemakers SMA; van der Spek PJ; van Dongen JJM; van der Velden VHJ; Rothova A; Langerak AW
Acta Ophthalmol; 2019 Sep; 97(6):626-632. PubMed ID: 30688042
[TBL] [Abstract][Full Text] [Related]
11. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With Methotrexate.
Gu J; Jiang T; Liu S; Chen X; Wang Z; Zhang P; Wang L; Jiang R; Huang X; Xu G; Chang Q
Am J Ophthalmol; 2023 Jul; 251():189-196. PubMed ID: 36963600
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
Eur J Ophthalmol; 2023 Nov; ():11206721231211931. PubMed ID: 37956540
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
15. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
Graefes Arch Clin Exp Ophthalmol; 2024 Mar; ():. PubMed ID: 38446203
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas.
Wang X; Su W; Gao Y; Feng Y; Wang X; Chen X; Hu Y; Ma Y; Ou Q; Liang D; Huang H
Haematologica; 2022 Sep; 107(9):2154-2162. PubMed ID: 35142151
[TBL] [Abstract][Full Text] [Related]
17. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
18. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.
Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC
Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.
Minezaki T; Usui Y; Asakage M; Takanashi M; Shimizu H; Nezu N; Narimatsu A; Tsubota K; Umazume K; Yamakawa N; Kuroda M; Goto H
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545709
[TBL] [Abstract][Full Text] [Related]
20. Vitreoretinal Lymphoma.
Sobolewska B; Chee SP; Zaguia F; Goldstein DA; Smith JR; Fend F; Mochizuki M; Zierhut M
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]